ALB and hepatocellular carcinoma: During further screening of crucial targets by using molecular docking analysis, the Pachyman-activated anti-HCC core targets, including ALB and VEGFA, were identified accordingly, characterized with potent binding activities of Pachyman with 6QIO and 5T89 proteins in HCC.